Gabriele Escherich

Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label, intergroup study

Andrea Biondi, Martin Schrappe, Paola De Lorenzo et al. · The Lancet Oncology · 2012 · 328 citations · Full text

Long-Term Outcome in Children With Relapsed Acute Lymphoblastic Leukemia After Time-Point and Site-of-Relapse Stratification and Intensified Short-Course Multidrug Chemotherapy: Results of Trial ALL-REZ BFM 90

Gesche Tallen, Richard Ratei, Georg Mann et al. · Journal of Clinical Oncology · 2010 · 310 citations

Mixed-phenotype Acute Leukemia, Immunology, Chemotherapy Intensity +20

Outcomes after Induction Failure in Childhood Acute Lymphoblastic Leukemia

Martin Schrappe, Stephen P. Hunger, Ching‐Hon Pui et al. · New England Journal of Medicine · 2012 · 292 citations · Full text

Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALL

Arian van der Veer, Esmé Waanders, Rob Pieters et al. · Blood · 2013 · 290 citations · Full text

Outcome of Infants Younger Than 1 Year With Acute Lymphoblastic Leukemia Treated With the Interfant-06 Protocol: Results From an International Phase III Randomized Study

Rob Pieters, Paola De Lorenzo, Philip Ancliffe et al. · Journal of Clinical Oncology · 2019 · 281 citations · Full text